[AKRO] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
04-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -5.37%
YoY- 5.29%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -25,831 -23,059 -35,542 -27,403 -26,029 -32,424 -24,330 4.07%
Tax -2,465 -2,574 -549 297 -22 -11 -51 1230.01%
NP -23,366 -20,485 -34,993 -27,403 -26,007 -32,424 -24,330 -2.66%
Tax Rate - - - - - - - -
Total Cost 23,366 20,485 34,993 27,403 26,007 32,424 24,330 -2.66%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.50 -0.44 -0.91 -0.77 -0.74 -0.93 -0.70 -20.11%
EPS Diluted -0.50 -0.44 -0.91 -0.77 -0.74 -0.93 -0.70 -20.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.